Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A novel ΔNp63-dependent immune mechanism improves prognosis of HPV-related head and neck cancer.
Mourtada J, Lony C, Nicol A, De Azevedo J, Bour C, Macabre C, Roncarati P, Ledrappier S, Schultz P, Borel C, Burgy M, Wasylyk B, Mellitzer G, Herfs M, Gaiddon C, Jung AC. Mourtada J, et al. Among authors: macabre c. Front Immunol. 2023 Oct 25;14:1264093. doi: 10.3389/fimmu.2023.1264093. eCollection 2023. Front Immunol. 2023. PMID: 38022675 Free PMC article.
Preferential Response of Basal-Like Head and Neck Squamous Cell Carcinoma Cell Lines to EGFR-Targeted Therapy Depending on EREG-Driven Oncogenic Addiction.
Job S, Reyniès A, Heller B, Weiss A, Guérin E, Macabre C, Ledrappier S, Bour C, Wasylyk C, Etienne-Selloum N, Brino L, Gaiddon C, Wasylyk B, Jung AC. Job S, et al. Among authors: macabre c. Cancers (Basel). 2019 Jun 8;11(6):795. doi: 10.3390/cancers11060795. Cancers (Basel). 2019. PMID: 31181806 Free PMC article.
Tumor-Suppressive and Immunomodulating Activity of miR-30a-3p and miR-30e-3p in HNSCC Cells and Tumoroids.
Conrad O, Burgy M, Foppolo S, Jehl A, Thiéry A, Guihard S, Vauchelles R, Jung AC, Mourtada J, Macabre C, Ledrappier S, Chenard MP, Onea MA, Danic A, Dourlhes T, Thibault C, Schultz P, Dontenwill M, Martin S. Conrad O, et al. Among authors: macabre c. Int J Mol Sci. 2023 Jul 6;24(13):11178. doi: 10.3390/ijms241311178. Int J Mol Sci. 2023. PMID: 37446353 Free PMC article.
Caveolin-1-negative head and neck squamous cell carcinoma primary tumors display increased epithelial to mesenchymal transition and prometastatic properties.
Jung AC, Ray AM, Ramolu L, Macabre C, Simon F, Noulet F, Blandin AF, Renner G, Lehmann M, Choulier L, Kessler H, Abecassis J, Dontenwill M, Martin S. Jung AC, et al. Among authors: macabre c. Oncotarget. 2015 Dec 8;6(39):41884-901. doi: 10.18632/oncotarget.6099. Oncotarget. 2015. PMID: 26474461 Free PMC article.
Cav1/EREG/YAP Axis in the Treatment Resistance of Cav1-Expressing Head and Neck Squamous Cell Carcinoma.
Burgy M, Jehl A, Conrad O, Foppolo S, Bruban V, Etienne-Selloum N, Jung AC, Masson M, Macabre C, Ledrappier S, Burckel H, Mura C, Noël G, Borel C, Fasquelle F, Onea MA, Chenard MP, Thiéry A, Dontenwill M, Martin S. Burgy M, et al. Among authors: macabre c. Cancers (Basel). 2021 Jun 18;13(12):3038. doi: 10.3390/cancers13123038. Cancers (Basel). 2021. PMID: 34207120 Free PMC article.